Abstract

Objective: Cerebral autoregulation limits the variability of cerebral blood flow (CBF) in the presence of systemic arterial blood pressure (ABP) changes. Monitoring cerebral autoregulation is important in the Neurocritical Care Unit (NCCU) to assess cerebral health. Here, our goal is to identify optimal frequency-domain near-infrared spectroscopy (FD-NIRS) parameters and apply a hemodynamic model of coherent hemodynamics spectroscopy (CHS) to assess cerebral autoregulation in healthy adult subjects and NCCU patients.Methods: In five healthy subjects and three NCCU patients, ABP oscillations at a frequency around 0.065 Hz were induced by cyclic inflation-deflation of pneumatic thigh cuffs. Transfer function analysis based on wavelet transform was performed to measure dynamic relationships between ABP and oscillations in oxy- (O), deoxy- (D), and total- (T) hemoglobin concentrations measured with different FD-NIRS methods. In healthy subjects, we also obtained the dynamic CBF-ABP relationship by using FD-NIRS measurements and the CHS model. In healthy subjects, an interval of hypercapnia was performed to induce cerebral autoregulation impairment. In NCCU patients, the optical measurements of autoregulation were linked to individual clinical diagnoses.Results: In healthy subjects, hypercapnia leads to a more negative phase difference of both O and D oscillations vs. ABP oscillations, which are consistent across different FD-NIRS methods and are highly correlated with a more negative phase difference CBF vs. ABP. In the NCCU, a less negative phase difference of D vs. ABP was observed in one patient as compared to two others, indicating a better autoregulation in that patient.Conclusions: Non-invasive optical measurements of induced phase difference between D and ABP show the strongest sensitivity to cerebral autoregulation. The results from healthy subjects also show that the CHS model, in combination with FD-NIRS, can be applied to measure the CBF-ABP dynamics for a better direct measurement of cerebral autoregulation.

Highlights

  • Cerebral autoregulation is a homeostatic feedback mechanism that maintains stable cerebral blood flow (CBF) despite moderate changes in arterial blood pressure (ABP)

  • We aim to demonstrate the feasibility of using these optical measurements with a protocol of blood-pressure-induced hemodynamic oscillations to monitor cerebral autoregulation efficiency in patients with brain injuries

  • The second goal of this study is to propose the applicability of the coherent hemodynamics spectroscopy (CHS) model to provide optical measurements of CBF-ABP dynamics, which is more directly related to the cerebral autoregulation efficiency than near-infrared spectroscopy (NIRS) measurements of O, D, and T, without any model

Read more

Summary

Introduction

Cerebral autoregulation is a homeostatic feedback mechanism that maintains stable cerebral blood flow (CBF) despite moderate changes in arterial blood pressure (ABP). A more positive phase shift between CBF vs ABP (i.e., a faster recovery of CBF in response to ABP changes) is often associated with an effective cerebral autoregulation [8, 10, 11, 13] This technique has been applied in the clinical setting to assess cerebral autoregulation in patients with intracranial hypertension [14], traumatic brain injury [15], acute ischemic stroke [16, 17], carotid artery occlusive disease [10], intracranial hemorrhage [4], etc. TCD together with ABP measurements have been widely used for autoregulation assessment in various population, TCD has its limitations as it cannot measure microvascular and localized changes in CBF

Methods
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call